Sumatriptan
IMITREX, Onzetra Xsail, Sumatriptan, TOSYMRA, ZEMBRACE SYMTOUCH
Serotonin-1b and Serotonin-1d Receptor Agonist
NADAC/unit
$0.2584
No Shortage
Tier 1: 172.0%
21 Manufacturers
42 ANDAs
vs. brand IMITREX: Generic saves up to 97% per unit
Active Shortages
2025-09-08 This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately February 28, 2026., Prasco Laboratories
2025-09-08 This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately March 16, 2026., Prasco Laboratories
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDCAPLIN STERILES LTDCIPLA LTDCURRAX PHARMACEUTICALS LLCDR REDDYS LABORATORIES INCEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAXOSMITHKLINEHIKMA FARMACEUTICA PORTUGAL SAHIKMA PHARMACEUTICALS USA INCIPCA LABORATORIES LTDLANNETT CO INCMYLAN PHARMACEUTICALS INCONESOURCE SPECIALTY PTE LTDORBION PHARMACEUTICALS PRIVATE LTDPADAGIS ISRAEL PHARMACEUTICALS LTDREGCON HOLDINGS LLCSUN PHARMACEUTICAL INDUSTRIES LTDTONIX MEDICINES INCVKT PHARMA PRIVATE LTDWATSON LABORATORIES INCWOCKHARDT BIO AGZHEJIANG BAYSIDE BIOTECH CO LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.